COOKE MICHAEL P. 4
4 · Magenta Therapeutics, Inc. · Filed Dec 2, 2019
Insider Transaction Report
Form 4
COOKE MICHAEL P.
Chief Scientific Officer
Transactions
- Sale
common stock
2019-12-02$13.21/sh−2,500$33,036→ 240,523 total - Sale
common stock
2019-12-02$13.31/sh−1,373$18,279→ 243,023 total - Sale
common stock
2019-12-02$12.74/sh−3,627$46,205→ 244,396 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $12.25 to $13.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $13.25 to $13.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $12.75 to $13.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.